BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

984 related articles for article (PubMed ID: 15665303)

  • 41. Carboplatin induces apoptotic cell death through downregulation of constitutively active nuclear factor-kappaB in human HPV-18 E6-positive HEp-2 cells.
    Singh S; Bhat MK
    Biochem Biophys Res Commun; 2004 May; 318(2):346-53. PubMed ID: 15120608
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells.
    Kim H; Chung H; Kim HJ; Lee JY; Oh MY; Kim Y; Kong G
    Breast Cancer Res Treat; 2008 Nov; 112(2):287-96. PubMed ID: 18158619
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomas.
    Pagel JM; Laugen C; Bonham L; Hackman RC; Hockenbery DM; Bhatt R; Hollenback D; Carew H; Singer JW; Press OW
    Clin Cancer Res; 2005 Jul; 11(13):4857-66. PubMed ID: 16000584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-kappaB signaling pathway.
    Kuo PL; Hsu YL; Lin TC; Tzeng WS; Chen YY; Lin CC
    Cancer Lett; 2007 Apr; 248(2):280-91. PubMed ID: 16963181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Over-expression of Bcl-2 against Pteris semipinnata L-induced apoptosis of human colon cancer cells via a NF-kappa B-related pathway.
    Chen GG; Liang NC; Lee JF; Chan UP; Wang SH; Leung BC; Leung KL
    Apoptosis; 2004 Sep; 9(5):619-27. PubMed ID: 15314290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of rituximab-resistant B-NHL clones: an in vitro model for studying tumor resistance to monoclonal antibody-mediated immunotherapy.
    Jazirehi AR; Bonavida B
    Methods Mol Biol; 2011; 731():407-19. PubMed ID: 21516425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
    Shehata M; Shehata M; Shehata F; Pater A
    Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
    Heckman CA; Mehew JW; Boxer LM
    Oncogene; 2002 May; 21(24):3898-908. PubMed ID: 12032828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential induction of apoptosis and MAP kinase signaling by mitochondrial toxicants in drug-sensitive compared to drug-resistant B-lineage lymphoid cell lines.
    O'Brien KA; Muscarella DE; Bloom SE
    Toxicol Appl Pharmacol; 2001 Aug; 174(3):245-56. PubMed ID: 11485385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD20-induced B cell death can bypass mitochondria and caspase activation.
    van der Kolk LE; Evers LM; Omene C; Lens SM; Lederman S; van Lier RA; van Oers MH; Eldering E
    Leukemia; 2002 Sep; 16(9):1735-44. PubMed ID: 12200688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydrogen peroxide in the Burkitt's lymphoma cell line Raji provides protection against arsenic trioxide-induced apoptosis via the phosphoinositide-3 kinase signalling pathway.
    Lu D; Bai XC; Gui L; Su YC; Deng F; Liu B; Li XM; Zeng WS; Cheng BL; Luo SQ
    Br J Haematol; 2004 May; 125(4):512-20. PubMed ID: 15142122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis.
    Baritaki S; Militello L; Malaponte G; Spandidos DA; Salcedo M; Bonavida B
    Int J Oncol; 2011 Jun; 38(6):1683-94. PubMed ID: 21455568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs.
    Alas S; Bonavida B
    Cancer Res; 2001 Jul; 61(13):5137-44. PubMed ID: 11431352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies.
    Treon SP; Mitsiades C; Mitsiades N; Young G; Doss D; Schlossman R; Anderson KC
    J Immunother; 2001; 24(3):263-71. PubMed ID: 11394505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.
    Hirsch B; Hummel M; Bentink S; Fouladi F; Spang R; Zollinger R; Stein H; Dürkop H
    Am J Pathol; 2008 Feb; 172(2):510-20. PubMed ID: 18187570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines.
    Arsura M; FitzGerald MJ; Fausto N; Sonenshein GE
    Cell Growth Differ; 1997 Oct; 8(10):1049-59. PubMed ID: 9342183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesis.
    Greten FR; Weber CK; Greten TF; Schneider G; Wagner M; Adler G; Schmid RM
    Gastroenterology; 2002 Dec; 123(6):2052-63. PubMed ID: 12454861
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
    Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
    Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of NF-kappaB oligonucleotide "decoys" on gene expression in P7 rat hippocampus after hypoxia/ischemia.
    Qiu J; Hu X; Nesic O; Grafe MR; Rassin DK; Wood TG; Perez-Polo JR
    J Neurosci Res; 2004 Jul; 77(1):108-18. PubMed ID: 15197744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53.
    Han SS; Chung ST; Robertson DA; Ranjan D; Bondada S
    Clin Immunol; 1999 Nov; 93(2):152-61. PubMed ID: 10527691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.